mouse anti ck7 Search Results


mouse anti-human ck7  (Nichirei Biosciences)
90
Nichirei Biosciences mouse anti-human ck7
Mouse Anti Human Ck7, supplied by Nichirei Biosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse anti-human ck7/product/Nichirei Biosciences
Average 90 stars, based on 1 article reviews
mouse anti-human ck7 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
monoclonal antibodies directed against ck20  (Bio SB Inc)
90
Bio SB Inc monoclonal antibodies directed against ck20
Histological images (magnification 200x) showing: ( A ) diffusely strongly <t>CK7</t> + adenocarcinoma with a weak focal CK20 staining regarded as CK20- tumor; ( B ) diffusely strongly CK7 + and CK20- adenocarcinoma of cecum infiltrating CK7-/CK20 + non-neoplastic mucosa; ( C ) tumor budding cells with strong CK7 + /CK20 + ; ( D ) adenocarcinoma showing moderate CK7 + in ca 20% of cells and CK20 + in ca 80% of cells; ( E ) adenocarcinoma with CK7 expression in isolated single cells (< 1%), and weak CK20 staining in ca 40% of cells, regarded as CK7-/CK20 + . The hematoxylin eosin images document glandular arrangement of colorectal adenocarcinoma, in line c with tumor budding.
Monoclonal Antibodies Directed Against Ck20, supplied by Bio SB Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/monoclonal antibodies directed against ck20/product/Bio SB Inc
Average 90 stars, based on 1 article reviews
monoclonal antibodies directed against ck20 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
cytokeratin-7 ncl-lck7-560  (Novocastra)
90
Novocastra cytokeratin-7 ncl-lck7-560
Histological images (magnification 200x) showing: ( A ) diffusely strongly <t>CK7</t> + adenocarcinoma with a weak focal CK20 staining regarded as CK20- tumor; ( B ) diffusely strongly CK7 + and CK20- adenocarcinoma of cecum infiltrating CK7-/CK20 + non-neoplastic mucosa; ( C ) tumor budding cells with strong CK7 + /CK20 + ; ( D ) adenocarcinoma showing moderate CK7 + in ca 20% of cells and CK20 + in ca 80% of cells; ( E ) adenocarcinoma with CK7 expression in isolated single cells (< 1%), and weak CK20 staining in ca 40% of cells, regarded as CK7-/CK20 + . The hematoxylin eosin images document glandular arrangement of colorectal adenocarcinoma, in line c with tumor budding.
Cytokeratin 7 Ncl Lck7 560, supplied by Novocastra, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cytokeratin-7 ncl-lck7-560/product/Novocastra
Average 90 stars, based on 1 article reviews
cytokeratin-7 ncl-lck7-560 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
mouse anti-ck-7  (Nordic BioSite)
90
Nordic BioSite mouse anti-ck-7
Histological images (magnification 200x) showing: ( A ) diffusely strongly <t>CK7</t> + adenocarcinoma with a weak focal CK20 staining regarded as CK20- tumor; ( B ) diffusely strongly CK7 + and CK20- adenocarcinoma of cecum infiltrating CK7-/CK20 + non-neoplastic mucosa; ( C ) tumor budding cells with strong CK7 + /CK20 + ; ( D ) adenocarcinoma showing moderate CK7 + in ca 20% of cells and CK20 + in ca 80% of cells; ( E ) adenocarcinoma with CK7 expression in isolated single cells (< 1%), and weak CK20 staining in ca 40% of cells, regarded as CK7-/CK20 + . The hematoxylin eosin images document glandular arrangement of colorectal adenocarcinoma, in line c with tumor budding.
Mouse Anti Ck 7, supplied by Nordic BioSite, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse anti-ck-7/product/Nordic BioSite
Average 90 stars, based on 1 article reviews
mouse anti-ck-7 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
anti-cytokeratin 7, 8, 18 and 19 antibodies  (Amersham Life Sciences Inc)
90
Amersham Life Sciences Inc anti-cytokeratin 7, 8, 18 and 19 antibodies
Histological images (magnification 200x) showing: ( A ) diffusely strongly <t>CK7</t> + adenocarcinoma with a weak focal CK20 staining regarded as CK20- tumor; ( B ) diffusely strongly CK7 + and CK20- adenocarcinoma of cecum infiltrating CK7-/CK20 + non-neoplastic mucosa; ( C ) tumor budding cells with strong CK7 + /CK20 + ; ( D ) adenocarcinoma showing moderate CK7 + in ca 20% of cells and CK20 + in ca 80% of cells; ( E ) adenocarcinoma with CK7 expression in isolated single cells (< 1%), and weak CK20 staining in ca 40% of cells, regarded as CK7-/CK20 + . The hematoxylin eosin images document glandular arrangement of colorectal adenocarcinoma, in line c with tumor budding.
Anti Cytokeratin 7, 8, 18 And 19 Antibodies, supplied by Amersham Life Sciences Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-cytokeratin 7, 8, 18 and 19 antibodies/product/Amersham Life Sciences Inc
Average 90 stars, based on 1 article reviews
anti-cytokeratin 7, 8, 18 and 19 antibodies - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
mouse anti-human cytokeratin 7 (ck7) antibody  (Zhongshan Company)
90
Zhongshan Company mouse anti-human cytokeratin 7 (ck7) antibody
Histological images (magnification 200x) showing: ( A ) diffusely strongly <t>CK7</t> + adenocarcinoma with a weak focal CK20 staining regarded as CK20- tumor; ( B ) diffusely strongly CK7 + and CK20- adenocarcinoma of cecum infiltrating CK7-/CK20 + non-neoplastic mucosa; ( C ) tumor budding cells with strong CK7 + /CK20 + ; ( D ) adenocarcinoma showing moderate CK7 + in ca 20% of cells and CK20 + in ca 80% of cells; ( E ) adenocarcinoma with CK7 expression in isolated single cells (< 1%), and weak CK20 staining in ca 40% of cells, regarded as CK7-/CK20 + . The hematoxylin eosin images document glandular arrangement of colorectal adenocarcinoma, in line c with tumor budding.
Mouse Anti Human Cytokeratin 7 (Ck7) Antibody, supplied by Zhongshan Company, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse anti-human cytokeratin 7 (ck7) antibody/product/Zhongshan Company
Average 90 stars, based on 1 article reviews
mouse anti-human cytokeratin 7 (ck7) antibody - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
mouse anti- ck- 7 antibody bsb5412  (Bio SB Inc)
90
Bio SB Inc mouse anti- ck- 7 antibody bsb5412
Histological images (magnification 200x) showing: ( A ) diffusely strongly <t>CK7</t> + adenocarcinoma with a weak focal CK20 staining regarded as CK20- tumor; ( B ) diffusely strongly CK7 + and CK20- adenocarcinoma of cecum infiltrating CK7-/CK20 + non-neoplastic mucosa; ( C ) tumor budding cells with strong CK7 + /CK20 + ; ( D ) adenocarcinoma showing moderate CK7 + in ca 20% of cells and CK20 + in ca 80% of cells; ( E ) adenocarcinoma with CK7 expression in isolated single cells (< 1%), and weak CK20 staining in ca 40% of cells, regarded as CK7-/CK20 + . The hematoxylin eosin images document glandular arrangement of colorectal adenocarcinoma, in line c with tumor budding.
Mouse Anti Ck 7 Antibody Bsb5412, supplied by Bio SB Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse anti- ck- 7 antibody bsb5412/product/Bio SB Inc
Average 90 stars, based on 1 article reviews
mouse anti- ck- 7 antibody bsb5412 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
mouse anti-human ck-7  (Diagnostica Stago)
90
Diagnostica Stago mouse anti-human ck-7
Histological images (magnification 200x) showing: ( A ) diffusely strongly <t>CK7</t> + adenocarcinoma with a weak focal CK20 staining regarded as CK20- tumor; ( B ) diffusely strongly CK7 + and CK20- adenocarcinoma of cecum infiltrating CK7-/CK20 + non-neoplastic mucosa; ( C ) tumor budding cells with strong CK7 + /CK20 + ; ( D ) adenocarcinoma showing moderate CK7 + in ca 20% of cells and CK20 + in ca 80% of cells; ( E ) adenocarcinoma with CK7 expression in isolated single cells (< 1%), and weak CK20 staining in ca 40% of cells, regarded as CK7-/CK20 + . The hematoxylin eosin images document glandular arrangement of colorectal adenocarcinoma, in line c with tumor budding.
Mouse Anti Human Ck 7, supplied by Diagnostica Stago, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse anti-human ck-7/product/Diagnostica Stago
Average 90 stars, based on 1 article reviews
mouse anti-human ck-7 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
anti–ck7 (mouse monoclonal ov-tl 12/30)  (Merck KGaA)
90
Merck KGaA anti–ck7 (mouse monoclonal ov-tl 12/30)
Histological images (magnification 200x) showing: ( A ) diffusely strongly <t>CK7</t> + adenocarcinoma with a weak focal CK20 staining regarded as CK20- tumor; ( B ) diffusely strongly CK7 + and CK20- adenocarcinoma of cecum infiltrating CK7-/CK20 + non-neoplastic mucosa; ( C ) tumor budding cells with strong CK7 + /CK20 + ; ( D ) adenocarcinoma showing moderate CK7 + in ca 20% of cells and CK20 + in ca 80% of cells; ( E ) adenocarcinoma with CK7 expression in isolated single cells (< 1%), and weak CK20 staining in ca 40% of cells, regarded as CK7-/CK20 + . The hematoxylin eosin images document glandular arrangement of colorectal adenocarcinoma, in line c with tumor budding.
Anti–Ck7 (Mouse Monoclonal Ov Tl 12/30), supplied by Merck KGaA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti–ck7 (mouse monoclonal ov-tl 12/30)/product/Merck KGaA
Average 90 stars, based on 1 article reviews
anti–ck7 (mouse monoclonal ov-tl 12/30) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Histological images (magnification 200x) showing: ( A ) diffusely strongly CK7 + adenocarcinoma with a weak focal CK20 staining regarded as CK20- tumor; ( B ) diffusely strongly CK7 + and CK20- adenocarcinoma of cecum infiltrating CK7-/CK20 + non-neoplastic mucosa; ( C ) tumor budding cells with strong CK7 + /CK20 + ; ( D ) adenocarcinoma showing moderate CK7 + in ca 20% of cells and CK20 + in ca 80% of cells; ( E ) adenocarcinoma with CK7 expression in isolated single cells (< 1%), and weak CK20 staining in ca 40% of cells, regarded as CK7-/CK20 + . The hematoxylin eosin images document glandular arrangement of colorectal adenocarcinoma, in line c with tumor budding.

Journal: Scientific Reports

Article Title: Cytokeratin 7 expression as a predictor of an unfavorable prognosis in colorectal carcinoma

doi: 10.1038/s41598-021-97480-4

Figure Lengend Snippet: Histological images (magnification 200x) showing: ( A ) diffusely strongly CK7 + adenocarcinoma with a weak focal CK20 staining regarded as CK20- tumor; ( B ) diffusely strongly CK7 + and CK20- adenocarcinoma of cecum infiltrating CK7-/CK20 + non-neoplastic mucosa; ( C ) tumor budding cells with strong CK7 + /CK20 + ; ( D ) adenocarcinoma showing moderate CK7 + in ca 20% of cells and CK20 + in ca 80% of cells; ( E ) adenocarcinoma with CK7 expression in isolated single cells (< 1%), and weak CK20 staining in ca 40% of cells, regarded as CK7-/CK20 + . The hematoxylin eosin images document glandular arrangement of colorectal adenocarcinoma, in line c with tumor budding.

Article Snippet: Concerning immunohistochemistry, 4 µm-thick tissue sections were stained using a Ventana BenchMark ULTRA autostainer (Ventana Medical Systems, Tucson, Arizona) using monoclonal antibodies directed against CK7 (clone OV-TL, BioSB, 1:500), CK20 (clone KS20.8, BioSB, 1:200), MSH2 (clone G219-1129, Roche, ready to use), PMS2 (clone A16-4, Roche, ready to use), MSH6 (clone 44, Roche, ready to use), and MLH1 (clone M1, Roche, ready to use).

Techniques: Staining, Expressing, Isolation

Summarizing of the distribution of CRCs according the cytokeratin profile and all studied variables; including p values of X-square test.

Journal: Scientific Reports

Article Title: Cytokeratin 7 expression as a predictor of an unfavorable prognosis in colorectal carcinoma

doi: 10.1038/s41598-021-97480-4

Figure Lengend Snippet: Summarizing of the distribution of CRCs according the cytokeratin profile and all studied variables; including p values of X-square test.

Article Snippet: Concerning immunohistochemistry, 4 µm-thick tissue sections were stained using a Ventana BenchMark ULTRA autostainer (Ventana Medical Systems, Tucson, Arizona) using monoclonal antibodies directed against CK7 (clone OV-TL, BioSB, 1:500), CK20 (clone KS20.8, BioSB, 1:200), MSH2 (clone G219-1129, Roche, ready to use), PMS2 (clone A16-4, Roche, ready to use), MSH6 (clone 44, Roche, ready to use), and MLH1 (clone M1, Roche, ready to use).

Techniques:

Bar chart from univariate logistic regression showing a ratio of low/high grade ( A ), right/left sided tumors ( B ) and I + II/III + IV UICC stage cases ( C ) among CK7 ± , CK20 ± and MMR-proficient/deficient CRCs. CK7 + CRCs are insignificantly more high-grade and right-sided. CK20 + CRCs are significantly more left-sided. MMR deficient CRCs are significantly more frequently high-grade, right-sided and low-stage.

Journal: Scientific Reports

Article Title: Cytokeratin 7 expression as a predictor of an unfavorable prognosis in colorectal carcinoma

doi: 10.1038/s41598-021-97480-4

Figure Lengend Snippet: Bar chart from univariate logistic regression showing a ratio of low/high grade ( A ), right/left sided tumors ( B ) and I + II/III + IV UICC stage cases ( C ) among CK7 ± , CK20 ± and MMR-proficient/deficient CRCs. CK7 + CRCs are insignificantly more high-grade and right-sided. CK20 + CRCs are significantly more left-sided. MMR deficient CRCs are significantly more frequently high-grade, right-sided and low-stage.

Article Snippet: Concerning immunohistochemistry, 4 µm-thick tissue sections were stained using a Ventana BenchMark ULTRA autostainer (Ventana Medical Systems, Tucson, Arizona) using monoclonal antibodies directed against CK7 (clone OV-TL, BioSB, 1:500), CK20 (clone KS20.8, BioSB, 1:200), MSH2 (clone G219-1129, Roche, ready to use), PMS2 (clone A16-4, Roche, ready to use), MSH6 (clone 44, Roche, ready to use), and MLH1 (clone M1, Roche, ready to use).

Techniques:

Kaplan Meier curves documenting CSS analysis concerning several selected variables. All death are showed in ( A ). There is a significantly worse survival in proximally situated tumors ( B ), advanced stage tumors ( C ), MMR-proficient tumors ( H ), CK7 + tumors using positivity cut-off on 10% ( E ) as well as on 1% ( F ). Using higher cut-off, the P -value is lower despite lower number of CK7 + cases (see discussion). Histopathological grade ( D ) is borderline insignificant despite visible trend in the curves. CK20 status ( G ) has no influence on survival.

Journal: Scientific Reports

Article Title: Cytokeratin 7 expression as a predictor of an unfavorable prognosis in colorectal carcinoma

doi: 10.1038/s41598-021-97480-4

Figure Lengend Snippet: Kaplan Meier curves documenting CSS analysis concerning several selected variables. All death are showed in ( A ). There is a significantly worse survival in proximally situated tumors ( B ), advanced stage tumors ( C ), MMR-proficient tumors ( H ), CK7 + tumors using positivity cut-off on 10% ( E ) as well as on 1% ( F ). Using higher cut-off, the P -value is lower despite lower number of CK7 + cases (see discussion). Histopathological grade ( D ) is borderline insignificant despite visible trend in the curves. CK20 status ( G ) has no influence on survival.

Article Snippet: Concerning immunohistochemistry, 4 µm-thick tissue sections were stained using a Ventana BenchMark ULTRA autostainer (Ventana Medical Systems, Tucson, Arizona) using monoclonal antibodies directed against CK7 (clone OV-TL, BioSB, 1:500), CK20 (clone KS20.8, BioSB, 1:200), MSH2 (clone G219-1129, Roche, ready to use), PMS2 (clone A16-4, Roche, ready to use), MSH6 (clone 44, Roche, ready to use), and MLH1 (clone M1, Roche, ready to use).

Techniques: